Compare, Analyse with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALKEM LABORATORIES   TEVA PHARMA
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
TEVA PHARMA
Dec-13
ALKEM LABORATORIES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,5892,965-   
Low Rs1,2322,576-   
Sales per share (Unadj.) Rs417.51,701.8-  
Earnings per share (Unadj.) Rs56.3106.3-  
Cash flow per share (Unadj.) Rs64.7243.9-  
Dividends per share (Unadj.) Rs12.7093.06-  
Dividend yield (eoy) %0.93.4 26.8%  
Book value per share (Unadj.) Rs292.91,890.4-  
Shares outstanding (eoy) m119.57848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.6 207.5%   
Avg P/E ratio x25.126.1 96.1%  
P/CF ratio (eoy) x21.811.4 191.9%  
Price / Book Value ratio x4.81.5 328.5%  
Dividend payout %22.687.5 25.8%   
Avg Mkt Cap Rs m168,6532,349,435 7.2%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m9,1710-   
Avg. sales/employee Rs ThNM32,108.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,005.8-  
INCOME DATA
Net Sales Rs m49,9151,443,107 3.5%  
Other income Rs m1,6450-   
Total revenues Rs m51,5611,443,107 3.6%   
Gross profit Rs m8,482395,196 2.1%  
Depreciation Rs m1,006116,648 0.9%   
Interest Rs m67128,345 2.4%   
Profit before tax Rs m8,451250,203 3.4%   
Minority Interest Rs m-1141,137 -10.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-164,244 0.0%   
Tax Rs m1,606-3,055 -52.6%   
Profit after tax Rs m6,73190,150 7.5%  
Gross profit margin %17.027.4 62.1%  
Effective tax rate %19.0-1.2 -1,556.5%   
Net profit margin %13.56.2 215.9%  
BALANCE SHEET DATA
Current assets Rs m27,062974,669 2.8%   
Current liabilities Rs m15,324849,994 1.8%   
Net working cap to sales %23.58.6 272.2%  
Current ratio x1.81.1 154.0%  
Inventory Days Days6791 73.2%  
Debtors Days Days4196 43.0%  
Net fixed assets Rs m12,610471,350 2.7%   
Share capital Rs m2393,552 6.7%   
"Free" reserves Rs m34,4900-   
Net worth Rs m35,0271,603,018 2.2%   
Long term debt Rs m1,212737,892 0.2%   
Total assets Rs m54,3873,297,961 1.6%  
Interest coverage x13.69.8 138.4%   
Debt to equity ratio x00.5 7.5%  
Sales to assets ratio x0.90.4 209.7%   
Return on assets %13.63.6 378.8%  
Return on equity %19.25.6 341.7%  
Return on capital %24.94.9 504.1%  
Exports to sales %12.90-   
Imports to sales %3.10-   
Net fx Rs m3,5520-   
CASH FLOW
From Operations Rs m7,259229,956 3.2%  
From Investments Rs m1,864-81,483 -2.3%  
From Financial Activity Rs m-9,273-275,848 3.4%  
Net Cashflow Rs m-150-127,375 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.04 Rs / USD

Compare ALKEM LABORATORIES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare ALKEM LABORATORIES With: DIVIS LABORATORIES  ALEMBIC LTD  TTK HEALTHCARE  CIPLA  GSK PHARMA  



Today's Market

Sensex Opens Higher; Consumer Durables and Energy Stocks Lead(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.7% while the Hang Seng is down 0.1%.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound? (The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks (Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Oct 15, 2019 11:23 AM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - FDC LTD. COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS